Cees Tijssen

5.3k total citations · 2 hit papers
72 papers, 3.6k citations indexed

About

Cees Tijssen is a scholar working on Neurology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Cees Tijssen has authored 72 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Neurology, 20 papers in Pulmonary and Respiratory Medicine and 19 papers in Genetics. Recurrent topics in Cees Tijssen's work include Glioma Diagnosis and Treatment (19 papers), Brain Metastases and Treatment (12 papers) and Intracranial Aneurysms: Treatment and Complications (11 papers). Cees Tijssen is often cited by papers focused on Glioma Diagnosis and Treatment (19 papers), Brain Metastases and Treatment (12 papers) and Intracranial Aneurysms: Treatment and Complications (11 papers). Cees Tijssen collaborates with scholars based in Netherlands, Curacao and France. Cees Tijssen's co-authors include Martin J. van den Bent, Thierry Gorlia, Martin Taphoorn, Alba A. Brandes, Marc Frénay, Denis Lacombe, Korné Jellema, Johan M. Kros, Anouk Allgeier and Hans J.J.A. Bernsen and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Cees Tijssen

68 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951

2012 804 citations Martin J. van den Bent, Alba A. Brandes et al. Journal of Clinical Oncology profile →
Adjuvant Procarbazine, Lomustine, and Vincristine Improves Progression-Free Survival but Not Overall Survival in Newly Diagnosed Anaplastic Oligodendrogliomas and Oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial

2006 523 citations Martin J. van den Bent, Alba A. Brandes et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Cees Tijssen

Since Specialization

Citations

This map shows the geographic impact of Cees Tijssen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cees Tijssen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cees Tijssen more than expected).

Fields of papers citing papers by Cees Tijssen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cees Tijssen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cees Tijssen. The network helps show where Cees Tijssen may publish in the future.

Co-authorship network of co-authors of Cees Tijssen

This figure shows the co-authorship network connecting the top 25 collaborators of Cees Tijssen. A scholar is included among the top collaborators of Cees Tijssen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cees Tijssen. Cees Tijssen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MGMT -STP27 Methylation Status as Predictive Marker for Response to PCV in Anaplastic Oligodendrogliomas and Oligoastrocytomas. A Report from EORTC Study 26951 2013 ·Clinical Cancer Research ·Martin J. van den Bent, Lale Erdem‐Eraslan, Ahmed Idbaïh, Johan de Rooi, Paul H.C. Eilers, Wim G.M. Spliet, Wilfred F.A. den Dunnen, Cees Tijssen, Pieter Wesseling, Peter A.E. Sillevis Smitt, Johan M. Kros, Thierry Gorlia, Pim J. French	95
2	New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951 2013 ·European Journal of Cancer ·Thierry Gorlia, Jean‐Yves Delattre, Alba A. Brandes, Johan M. Kros, Martin Taphoorn, Mathilde C.M. Kouwenhoven, H. J. J. A. Bernsen, Marc Frénay, Cees Tijssen, Denis Lacombe, Martin J. van den Bent	48
3	Sciatica-like symptoms and the sacroiliac joint: clinical features and differential diagnosis 2013 ·European Spine Journal ·Leo H. Visser, (unknown), Cees Tijssen, Joost J. van Middendorp, Jolanda Schieving	33
4	Identification of drug-related problems by a clinical pharmacist in addition to computerized alerts 2013 ·International Journal of Clinical Pharmacy ·Rianne J. Zaal, M. Jansen, (unknown), Cees Tijssen, Jan A. Roukema, Patricia M. L. A. van den Bemt	39
5	Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951 breakdown → 2012 ·Journal of Clinical Oncology ·Martin J. van den Bent, Alba A. Brandes, Martin Taphoorn, Johan M. Kros, Mathilde C.M. Kouwenhoven, Jean‐Yves Delattre, Hans J.J.A. Bernsen, Marc Frénay, Cees Tijssen, Wolfgang Grisold, László Sípos, Roelien H. Enting, Pim J. French, Winand N.M. Dinjens, Charles J. Vecht, Anouk Allgeier, Denis Lacombe, Thierry Gorlia, Khê Hoang‐Xuan	804
6	LONG-TERM FOLLOW-UP OF EORTC 26951, A RANDOMIZED TRIAL ON ADJUVANT PCV CHEMOTHERAPY IN ANAPLASTIC OLIGODENDROGLIAL TUMORS. A REPORT OF THE EORTC BTG. 2012 ·Data Archiving and Networked Services (DANS) ·Martin J. van den Bent, Alba A. Brandes, Martin Taphoorn, Johan M. Kros, Mathilde C.M. Kouwenhoven, Jean‐Yves Delattre, (unknown), Marc Frénay, Cees Tijssen, Wolfgang Grisold, (unknown), Roelien H. Enting, Pim J. French, Winand N.M. Dinjens, Charles J. Vecht, Anouk Allgeier, Denis Lacombe, Thierry Gorlia, Khê Hoang‐Xuan	0
7	Supraorbital Neuralgia Caused by Nerve Entrapment Visualized on Ultrasonography 2012 ·Headache The Journal of Head and Face Pain ·Cees Tijssen, (unknown), Leo H. Visser	6
8	LONG TERM FOLLOW-UP RESULTS OF EORTC 26951: A RANDOMIZED PHASE III STUDY ON ADJUVANT PCV CHEMOTHERAPY IN ANAPLASTIC OLIGODENDROGLIAL TUMORS - A REPORT OF THE EORTC BRAIN TUMOR GROUP 2012 ·Neuro-Oncology ·Martin J. van den Bent, Alba A. Brandes, Martin Taphoorn, Johan M. Kros, Mathilde C.M. Kouwenhoven, J. Delattre, H. J. J. A. Bernsen, Marc Frénay, Cees Tijssen, Wolfgang Grisold, László Sípos, Roelien H. Enting, Pim J. French, Winand N.M. Dinjens, C. J. Vecht, Anouk Allgeier, Denis Lacombe, Thierry Gorlia, Khê Hoang‐Xuan	0
9	IDH1 and IDH2 Mutations Are Prognostic but not Predictive for Outcome in Anaplastic Oligodendroglial Tumors: A Report of the European Organization for Research and Treatment of Cancer Brain Tumor Group 2010 ·Clinical Cancer Research ·Martin J. van den Bent, Hendrikus J. Dubbink, Yannick Marie, Alba A. Brandes, Martin Taphoorn, Pieter Wesseling, Marc Frénay, Cees Tijssen, Denis Lacombe, Ahmed Idbaïh, Ronald van Marion, Johan M. Kros, Winand N.M. Dinjens, Thierry Gorlia, Marc Sanson	304
10	Secondary meningioma in a long-term survivor of atypical teratoid/rhabdoid tumour with a germline INI1 mutation 2008 ·Child s Nervous System ·(unknown), M.P.W.A. Houben, Cees Tijssen, Pieter Wesseling, Theo J.M. Hulsebos	9
11	Long-term survival and transmission of INI1-mutation via nonpenetrant males in a family with rhabdoid tumour predisposition syndrome 2007 ·British Journal of Cancer ·(unknown), (unknown), M.P.W.A. Houben, Frank Baas, Cees Tijssen, Johannes L. Teepen, Pieter Wesseling, Theo J.M. Hulsebos	47
12	Spinal dural arteriovenous fistulas: a congestive myelopathy that initially mimics a peripheral nerve disorder 2006 ·Brain ·Korné Jellema, Cees Tijssen, J. van Gijn	202
13	Embolization of spinal dural arteriovenous fistulas: importance of occlusion of the draining vein 2005 ·Journal of Neurosurgery Spine ·Korné Jellema, M. Sluzewski, Willem Jan van Rooij, Cees Tijssen, Guus Beute	63
14	Spinal dural arteriovenous fistulas—An underdiagnosed disease 2005 ·Journal of Neurology ·Korné Jellema, Cees Tijssen, M. Sluzewski, F Asbeck, P. J. Koudstaal, J. van Gijn	27
15	Type I cerebral dural arteriovenous fistulas of the lateral sinus: clinical features in 24 patients 2004 ·European Journal of Neurology ·(unknown), W.J. van Rooij, M. Sluzewski, Cees Tijssen	2
16	Prediction of intracranial metastases in cancer patients with headache 2002 ·Cancer ·(unknown), Johannes C. Kelder, (unknown), Cees Tijssen	36
17	Spinal astrocytoma with intracranial metastases 1994 ·Journal of Neuro-Oncology ·Cees Tijssen, M. Sluzewski	4
18	Epileptic eye deviation 1993 ·Neuro-Ophthalmology ·Cees Tijssen, (unknown), (unknown)	2
19	Eye movement disorder: An early expression of the myotonic dystrophy gene? 1992 ·Muscle & Nerve ·J.P. ter Bruggen, Cees Tijssen, Han G. Brunner, Bernard A. van Oost, (unknown)	4
20	Octavus Nerve Neurovascular Compression Syndrome 1987 ·European Neurology ·J.P. ter Bruggen, R.W.M. Keunen, Cees Tijssen, D. Wijnalda	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact